CAMBRIDGE, Mass. (AP) _ Momenta Pharmaceuticals Inc. (MNTA) on Wednesday reported a loss of $50.3 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 65 cents. Losses, adjusted for restructuring costs, were 45 cents per share.
The biotechnology company posted revenue of $14.9 million in the period.
Momenta shares have increased slightly more than 3 percent since the beginning of the year. The stock has risen 4 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MNTA at https://www.zacks.com/ap/MNTA